Presentations

OBJETIVOS TERAPEUTICOS DE LA PRESION ARTERIAL EN LAS COMORBILIDADES

solaci
solaci
356
0

18_luz_cabral
Por: Dra. Luz T. Cabral G. MD. FACC

Previous article
ASOCIACION DE DROGAS O DROGA UNICA en HTA
Next article
Nuevas estrategias antitrombóticas. ¿Incrementan los beneficios?
solaci
solaci

More articles by this author

Recambio valvular aórtico tradicional: PARTNER 5 anos

solaci - 0
By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil

Estenosis aórtica severa con bajo flujo, bajo gradiente y disfunción sistólica

solaci - 0
By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.)

Prevención de la enfermedad cardiovascular y ejercicio físico en el adulto: ¿ una cuestión de intensidad?

solaci - 0
By: Dra. María Carolina Acosta Cazal

Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.

solaci - 0
By: Dr. Marcelo Halac Hospital Italiano - Buenos Aires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Recambio valvular aórtico tradicional: PARTNER 5 anos

By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Dr. Omar Tupayachi - 0
Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Dr. Omar Tupayachi - 0
Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

Dr. Omar Tupayachi - 0
The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...